Indian pharmaceutical companies will soon be rated by the US on the basis of quality parameters met by them. The US Food and Drug Administration (US FDA) is working on developing quality metrics to categorise drug companies according to their adherence to norms, which will determine how they are perceived by buyers. The metrics will be applied on firms across the world, including the US. USFDA is working with its regulatory counterparts around the world.
Extracted from HBL, Mar 18,’15